IBDEI20E ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34085,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,34085,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,34086,0)
 ;;=Z82.71^^131^1681^47
 ;;^UTILITY(U,$J,358.3,34086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34086,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,34086,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,34086,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,34087,0)
 ;;=Z82.1^^131^1681^23
 ;;^UTILITY(U,$J,358.3,34087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34087,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,34087,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,34087,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,34088,0)
 ;;=Z82.2^^131^1681^27
 ;;^UTILITY(U,$J,358.3,34088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34088,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,34088,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,34088,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,34089,0)
 ;;=Z84.0^^131^1681^48
 ;;^UTILITY(U,$J,358.3,34089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34089,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,34089,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,34089,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,34090,0)
 ;;=Z82.79^^131^1681^26
 ;;^UTILITY(U,$J,358.3,34090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34090,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,34090,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,34090,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,34091,0)
 ;;=Z84.89^^131^1681^46
 ;;^UTILITY(U,$J,358.3,34091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34091,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,34091,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,34091,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,34092,0)
 ;;=Z81.1^^131^1681^20
 ;;^UTILITY(U,$J,358.3,34092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34092,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,34092,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,34092,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,34093,0)
 ;;=Z82.62^^131^1681^45
 ;;^UTILITY(U,$J,358.3,34093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34093,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,34093,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,34093,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,34094,0)
 ;;=Z83.71^^131^1681^25
 ;;^UTILITY(U,$J,358.3,34094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34094,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,34094,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,34094,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,34095,0)
 ;;=Z84.81^^131^1681^29
 ;;^UTILITY(U,$J,358.3,34095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34095,1,3,0)
 ;;=3^Family Hx of Genetic Disease
 ;;^UTILITY(U,$J,358.3,34095,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,34095,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,34096,0)
 ;;=Z86.010^^131^1681^76
 ;;^UTILITY(U,$J,358.3,34096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34096,1,3,0)
 ;;=3^Personal Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,34096,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,34096,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,34097,0)
 ;;=Z86.14^^131^1681^81
 ;;^UTILITY(U,$J,358.3,34097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34097,1,3,0)
 ;;=3^Personal Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,34097,1,4,0)
 ;;=4^Z86.14
 ;;^UTILITY(U,$J,358.3,34097,2)
 ;;=^5063464
 ;;^UTILITY(U,$J,358.3,34098,0)
 ;;=Z86.31^^131^1681^77
 ;;^UTILITY(U,$J,358.3,34098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34098,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
